These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 1779334

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Cases of neuroblastoma missed by the mass screening programs.
    Nishi M, Miyake H, Takeda T, Takasugi N, Sato Y, Hanai J, Kawai T.
    Pediatr Res; 1989 Dec; 26(6):603-7. PubMed ID: 2602040
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Clinical significance of catecholamine excretion levels in diagnosis and treatment of neuroblastoma.
    Bond JV.
    Arch Dis Child; 1975 Sep; 50(9):691-5. PubMed ID: 1190818
    [Abstract] [Full Text] [Related]

  • 31. Composite ganglioneuroblastoma--a case report and short term culture of tumor cells.
    Ishikawa S, Suzuki T, Oboshi S, Itoh S, Watanabe W.
    Acta Pathol Jpn; 1980 Jan; 30(1):101-8. PubMed ID: 7361544
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Neuroblastoma. Mass screening for early detection and its prognosis.
    Sawada T, Kidowaki T, Sakamoto I, Hashida T, Matsumura T, Nakagawa M, Kusunoki T.
    Cancer; 1984 Jun 15; 53(12):2731-5. PubMed ID: 6722733
    [Abstract] [Full Text] [Related]

  • 35. Continued remission in children with neuroblastoma despite elevations of urinary catecholamine metabolites.
    Horn M, Blatt J.
    Am J Pediatr Hematol Oncol; 1992 Aug 15; 14(3):202-6. PubMed ID: 1510188
    [Abstract] [Full Text] [Related]

  • 36. Serum vanillylmandelic acid/homovanillic acid contributes to prognosis estimation in patients with localised but not with metastatic neuroblastoma.
    Berthold F, Hunneman DH, Harms D, Käser H, Zieschang J.
    Eur J Cancer; 1992 Aug 15; 28A(12):1950-4. PubMed ID: 1419287
    [Abstract] [Full Text] [Related]

  • 37. The neuroblastoma.
    Koop CE.
    Prog Pediatr Surg; 1972 Aug 15; 4():1-28. PubMed ID: 4570199
    [No Abstract] [Full Text] [Related]

  • 38. Three years of experience with random urinary homovanillic and vanillylmandelic acid levels in the diagnosis of neuroblastoma.
    Tuchman M, Ramnaraine ML, Woods WG, Krivit W.
    Pediatrics; 1987 Feb 15; 79(2):203-5. PubMed ID: 3808793
    [Abstract] [Full Text] [Related]

  • 39. Significance of catecholamine excretion in the follow-up of sympathoblastomas.
    Barontini de Gutiérrez, Bergadá C, Becú L.
    Cancer; 1971 Jan 15; 27(1):228-32. PubMed ID: 4321900
    [No Abstract] [Full Text] [Related]

  • 40. Development of a new biochemical test to diagnose and monitor neuroblastoma in Vietnam: homovanillic and vanillylmandelic acid by gas chromatography-mass spectrometry.
    Tran MT, Baglin J, Tran TT, Hoang KT, Phung LT, Read A, Greaves RF.
    Clin Biochem; 2014 Feb 15; 47(3):206-15. PubMed ID: 24296288
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.